Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

464 PSORALENS
Prurigo
(1982): Stüttgen G, Int J Dermatol 21, 198 (passim)
Pruritus (>10%)
(1990): Roelandts R+, Photodermatol Photoimmunol Photomed
7, 141
(1982): Stüttgen G, Int J Dermatol 21, 198 (passim)
Psoriasis
Rash (sic) (1–10%)
Rosacea
(1989): McFadden JP+, Br J Dermatol 121, 413
Scleroderma
Seborrheic dermatitis
(1983): Tegner E, Acta Derm Venereol (Stockh) Suppl 107, 5
Squamous cell carcinoma
(2002): Katz KA+, J Invest Dermatol 118(6), 1038
(1986): Kahn JR+, Clin Exp Dermatol 11, 398
Urticaria
(1994): Bech-Thomsen N+, JAmAcadDermatol31, 1063
Vasculitis
(1981): Barriere H+, Presse Med (French) 10, 37
Verrucae
(1982): Stüttgen G, Int J Dermatol 21, 198
Vesiculation
(1993): Sheehan MP+, Br J Dermatol 129, 431 (PUVA)
(1991): No Author, Ned Tijdschr Geneeskd (Dutch) 135, 1764
Vitiligo
(1983): Tegner E, Acta Derm Venereol (Stockh) 107 (Suppl), 5
Mucosal
Cheilitis (1–10%)
Hair
Hair – hypertrichosis
(1992): Shelley WB+, Advanced Dermatologic Diagnosis WB
Saunders, 725 (passim)
(1983): Rampen FHJ, Br J Dermatol 109, 657
Nails
Nails – photo-onycholysis
(2002): Baran R+, Photodermatol Photoimmunol Photomed
18(4), 202
Nails – pigmentation
(1990): Trattner A+, Int J Dermatol 29, 310
(1989): Weiss E+, Int J Dermatol 28, 188
(1986): MacDonald KJS+, Br J Dermatol 114, 395
(1982): Naik RPC+, Int J Dermatol 21, 275
Other
Anaphylactoid reactions/Anaphylaxis
(2003): Park JY+, Photodermatol Photoimmunol Photomed
19(1), 37
(2001): Legat FJ+, Br J Dermatol 145(5), 821
Lymphoproliferative disease
(1989): Aschinoff R+, JAmAcadDermatol21, 1134
Pain
(1993): Burrows NP+, Br J Dermatol 129, 504
(1987): Norris PG+, Clin Exp Dermatol 12, 403
(1983): Tegner E, Acta Derm Venereol (Stockh) Suppl 107, 5
Tumors (for the most part malignant)
(2004): McKenna KE, Photodermatol Photoimmunol Photomed
20(6), 289
(1995): Weinstock MA+, Arch Dermatol 131, 701
(1994): Altman JS+, JAmAcadDermatol31, 505
(1994): Lever LR+, Clin Exp Dermatol 19, 443 (malignant)
(1994): Lewis FM+, Lancet 344, 1157
(1993): Lindelof B+, Br J Dermatol 129, 39
(1990): Young AR, J Photochem Photobiol B 6, 237
(1989): Hannuksela M+, JAmAcadDermatol21, 813
(1989): Stern RS+, Carcinog Compr Surv 11, 85
(1988): Gupta AK+, JAmAcadDermatol19, 67
(1987): Henseler T+, JAmAcadDermatol16, 108
(1983): Farber EM+, Arch Dermatol 119, 426
(1983): Shafrir A, Harefuah (Hebrew) 104, 364
(1981): No Author, BrMedJClinRedEd283, 335
(1980): Brown FS+, JAmAcadDermatol2, 393
(1980): Halprin KM, JAmAcadDermatol2, 334
(1980): Halprin KM, JAmAcadDermatol2, 432
PYRAZINAMIDE
Trade names: Braccopril; Dipimide; Isopas; Lynamide; Pirilene;
Pyrazide; Pyrazinamide (Clonimel); Rifater (Sanofi-Aventis);
Rozide; Tebrazid; Zinastat
Indications: Tuberculosis
Category: Antibiotic
Half-life: 9–10 hours
Clinically important, potentially hazardous interactions
with: rifampin
Reactions
Skin
Acne (